Trinuclear rhenium(i)-based metallocages as anticancer agents towards human cervical cancer cells
In vitro cytotoxicity studies of self-assembled compact trinuclear rhenium(I) based metallocages display anticancer, antimetastatic, antiproliferative and DNA damaging behavior towards human cervical cancer cells comparable to that of cisplatin.
